Alfie Health ’ s New AI-Powered ObesityRx Platform Helps Determine Sustainable Weight Loss Approach for Patients with Obesity, Using Precision Medicine and Telehealth Support

With $2.1 Million in Funding, Alfie Health Reports a Cohort of 300 Patients Lost an Average of 10-15% of Body Weight over Nine Months of Following its Holistic Approach The AI Platform Analyzes Patient Data, Recommends Medication (or Combination Meds) Precisely Prescribed, as well as Behavioral Changes, and Provides Ongoing Telehealth Support With 42 percent of Americans now struggling with obesity, doctors and their patients are looking for a sustainable approach to weight loss. Currently, prescription medications known as the GLP-1 class of anti-obesity medications (such as Ozempic®, Wegovy®, Mounjaro, etc.) are becoming extremely popular as a way to lose 10-15 percent of body weight on average. However, these drugs can come with significant issues and downsides. Now a new virtual clinic for patients with obesity, Alfie Health, is announcing $2.1 million in funding led by Y Combinator and Nina Capital, along with Goodwater Capital, Phoenix Investment Club, and various angels including the founder of unicorn Opentrons. It is also announcing results achieved by a 300-person cohort of patients who in nine months lost an average of 10 to 15 percent of their body weight—similar to the results of GLP-1s—by adhering to Alfie Health’s holistic approach.  Developed with input from obesity specialists from Mass General and the Cleveland Clinic, the proprietary ObesityRx system utilizes AI to conduct a metabolic profile of patients to understand why they gain and hold on...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Health IT Company Healthcare IT Alexander Singh Alfie Health Cleveland Clinic Cleveland Clinic's Bariatric and Metabolic Institute Dr. W. Scott Butsch GLP-1 Goodwater Capital Health IT Funding Health IT Fundings Health IT Investment Source Type: blogs